Serum Amyloid A: How to Run the VMRD Test and About SAA Use in Practice
- VMRD | 2020-10-05
Watch and learn how to run VMRD’s point-of-care lateral flow test for equine serum amyloid A (SAA) for horse-side results!
Read More
Serum Amyloid A (SAA) Screening for General Health and Biosecurity
- Siddra Hines, DVM, PhD, DACVIM-LA | 2020-08-04
Routine equine health exams and biosecurity strategies utilize screening methods to detect underlying performance-limiting issues and potential infectious disease concerns. The fundamental basis of this is a good physical exam with rectal temperature screening, however subclinical issues may still exist...
Read More
Serum Amyloid A (SAA) Testing to Differentiate and Monitor Synovial Sepsis
- Siddra Hines, DVM, PhD, DACVIM-LA | 2020-07-16
Early and accurate detection of septic arthritis/synovitis is critical to minimize damage to cartilage and other structures that can ultimately affect the horse’s return to function and long-term prognosis. By the time diagnosis is clear cut, a...
Read More
Independent External Validation of the VMRD Serum Amyloid A (SAA) Test
- Dr. Siddra Hines, DVM, PhD, DACVIM-LA | 2020-07-02
To build on the internal validation performed by VMRD, our Serum Amyloid A (SAA) test was independently evaluated by at the University of California-Davis. Blood samples were collected from horses with acute inflammation, and results were compared between sample types...
Read More
Using Serum Amyloid A (SAA) Testing to Monitor Patients
- Dr. Siddra Hines, DVM, PhD, DACVIM-LA | 2020-03-31
The dynamic nature of SAA makes it an ideal marker for monitoring progression or resolution of illness, including response to treatment.1-6 It is rapidly responsive to clinical changes and directly reflects the inflammatory status of the horse. Point-of-care testing...
Read More
Unexpected Results and Confounding Factors in Serum Amyloid A (SAA) Testing
- Dr. Siddra Hines, DVM, PhD, DACVIM-LA | 2020-03-31
To avoid unexpected SAA results it is critical to understand basic SAA biology and interpret results in light of other clinical data. Presenting complaint and duration of disease are particularly valuable to consider when a normal or low result is...
Read More
Validation and Performance of the FMDV cELISA
- Siddra Hines | 2017-06-01
Read More Here: Validation and performance of the FMDV cELISA By: Siddra Hines Date: 05/26/17
Read More
Reduce losses from Neospora caninum through serological testing
- Siddra Hines, DVM, Ph.D. | 2015-09-01
Neospora caninum is one of the leading causes of abortion and decreased reproductive efficiency in cattle.1,2 This protozoan parasite is insidious, often with abortion as the only obvious sign of disease. Median economic cost of Neospora abortion has been estimated...
Read More
Is Equine Infectious Anemia (EIA) Still a Threat?
- Travis C. McGuire, D.V.M., Ph.D., Director of Research | 2009-05-01
EIA is still clearly a threat; however the threat is less than in the 1970s. The overall percentage of EIA positive horses among those tested in the United States decreased from near 4% in 1972 to <0.01% in 20051. Prior to the...
Read More
BLV Update
- Scott Adams, D.V.M., Ph.D., President and CEO | 2009-05-01
Many of our customers have considered and some have asked about published sensitivity and specificity data Bovine Leukemia Virus Antibody Test Kit, ELISA (Cat. No. 284; 1 Plate and 284-5; 5 Plate). We publish our field validation data as required...
Read More